Some of the “strategic alternatives” include “a sale of part or all of the company, recapitalization or other partnership opportunities,” Premier said May 8.
The company said it is not promising a transaction or change and it will not “comment further on this strategic review unless and until the board has approved a specific course of action or until it determines that further disclosure is appropriate or required by law.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
